We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

SEROSEP

Serosep Ltd. is one of Ireland’s leading diagnostics specialists and an innovative, specialist partner of choice for ... read more Featured Products: More products

Download Mobile App





Serosep Exhibits EntericBio System for Testing, Detecting and Identifying GI Pathogens at MEDICA 2022

By LabMedica International staff writers
Posted on 14 Nov 2022

Serosep Ltd. More...

(Limerick Ireland) is exhibiting its unique system that is revolutionizing molecular testing of gastrointestinal (GI) pathogens at the MEDICA 2022 International Trade Fair being held on November 14-17 in Düsseldorf, Germany. MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals.

At MEDICA 2022, Serosep is exhibiting its EntericBio system which is the market leader in GI realtime PCR testing in the UK/Ireland and provides medium/high throughput labs with a rapid, reliable and easy to use solution for their enteric pathogen testing needs. The EntericBio system is unique as it is capable of detecting target DNA and RNA directly from stool specimens, circumventing the requirement for commercial nucleic acid extraction purification and minimizes hands on time for the laboratory personnel. The EntericBio system provides a complete and flexible modular menu for testing, detecting and identifying GI pathogens including bacteria, parasites, CPE and viruses within the same work-flow and platform with a result for up to 46 specimens per run in les than three hours and results for consecutive runs each hour.

Serosep is also highlighting its comprehensive range of pre-filled Histopot specimen containers for use in histology and pathology laboratories. These biopsy sample containers are manufactured to the highest standard, using quality state of the art production techniques, in a certified manufacturing facility. The HistoPot ensures the safety during patients’ biopsy sample fixation, which is the single most important stage in the histopathology process. The HistoPot is regarded as one of the benchmarks for the fixation and transportation of millions of critical histological samples worldwide.

Related Links:
Serosep Ltd.


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Prefilled Tubes
Prefilled 5.0ml Tubes
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Microbiology

view channel
Image: Graphical Abstract (Emery, J. K., V. Nemidkanam, N. Colon, et al. Journal of Extracellular Vesicles (2026). https://doi.org/10.1002/jev2.70286)

Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori

Helicobacter pylori infects an estimated 43.9% of the global population, affecting approximately 4.4 billion people worldwide. In many regions, including Africa, Eastern Europe, and Southeast Asia, prevalence... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.